Bullboard - Stock Discussion Forum Bioxytran Inc BIXT

Healthcare Biotechnology

Bioxytran, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the development, manufacture, and commercialization of therapeutic drugs designed to address hypoxia in humans. The Company's lead drug candidate, code named BXT-25, is an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer with an intended application, which includes... see more

Add To Watchlist

OTCQB:BIXT - Post Discussion

Bioxytran Inc > "$BIXT Valuation Highlights Promising Biotech Potential"

View:

Post by amritadanique on Oct 26, 2023 8:58am

"$BIXT Valuation Highlights Promising Biotech Potential"

The present market capitalization of Bioxytran, Inc. ($BIXT) stands at $23.09 million, reflecting its promising potential in the biotech industry. This valuation underscores the company's commitment to advancing healthcare and addressing critical medical challenges, particularly in the fields of glycovirology, hypoxia, and degenerative diseases. With innovative solutions in the pipeline, Bioxytran is on a path to positively impact patient well-being and medical science.